Antifibrotic Effect of Apremilast in Systemic Sclerosis Dermal Fibroblasts and Bleomycin-Induced Mouse Model

The authors conducted experiments focusing on the antifibrotic and anti-inflammatory effects of apremilast using dermal fibroblasts derived from patients with systemic sclerosis and an systemic sclerosis mouse model.